NCT00568568View on ClinicalTrials.gov

Metabolic Studies- Interactions Between GH and Insulin in GHDA

NACompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions

Insulin Resistance

Interventions

DRUG

Growth hormone

GH infusion from 8.00 pm to 03.00 am (dose 10,2 ng/kg/min) c) GH infusion from 02.00 am to 09.00 am (dose 10,2 ng/kg/min).

Trial Locations (1)

8000

Department M (endocrinology and diabets), Aarhus

Sponsors

Collaborators (1)

Novo Nordisk A/S

All Listed Sponsors

collaborator

Aarhus University Hospital

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Aarhus

OTHER

NCT00568568 - Metabolic Studies- Interactions Between GH and Insulin in GHDA | Biotech Hunter | Biotech Hunter